0001104659-19-011613.txt : 20190408 0001104659-19-011613.hdr.sgml : 20190408 20190228172745 ACCESSION NUMBER: 0001104659-19-011613 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elanco Animal Health Inc CENTRAL INDEX KEY: 0001739104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 825497352 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 BUSINESS PHONE: 877-352-6261 MAIL ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 CORRESP 1 filename1.htm

 

Elanco Animal Health Incorporated

2500 Innovation Way

Greenfield, Indiana

 

VIA EDGAR

 

February 28, 2019

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, DC 20549-3628

Attn:                    Jeffrey Gabor

 

Re:                             Request for Acceleration of Effectiveness

Elanco Animal Health Incorporated

Registration Statement on Form S-4 (File No. 333-229577)

 

Dear Mr. Gabor:

 

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Elanco Animal Health Incorporated (the “Registrant”) hereby respectfully requests that the effectiveness of the Registration Statement on Form S-4 (File No. 333-229577) filed by the Registrant on February 8, 2019, as amended by Amendment No. 1 filed on February 22, 2019 (the “Registration Statement”), be accelerated by the U.S. Securities and Exchange Commission so that it may become effective at 4:00 p.m., Eastern time, on March 4, 2019, or as soon as practicable thereafter.

 

Please contact Raymond O. Gietz via phone at 212-310-8702 or via email at raymond.gietz@weil.com to confirm the effectiveness of the Registration Statement.

 

 

Sincerely,

 

Elanco Animal Health Incorporated

 

 

By:

/s/ Michael-Bryant Hicks

 

Name:

Michael-Bryant Hicks

 

Title:

General Counsel

 

 

 

cc:                    Raymond O. Gietz

Weil, Gotshal & Manges LLP
(via email)